3.9 Article

Aggressive pituitary lesion with a remarkably high Ki-67

期刊

出版社

SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
DOI: 10.1590/0004-2730000003116

关键词

-

资金

  1. Associacao de Endocrinologia Oncologica

向作者/读者索取更多资源

The uncommon aggressive pituitary tumors are named carcinomas when metastases are detected, either in the central nervous system and/or systemically. Some cases are associated with hormonal overproduction, but most are diagnosed because of local symptoms. These neoplasias are generally refractory to current treatments. A 51 year-old woman presented sudden onset of headache, left arm paresis and left facial hypoesthesia. Computed tomography scan and magnetic resonance imaging revealed a pituitary tumor invading the left sphenoidal and cavernous sinuses. Laboratory data excluded hormonal hypersecretion. The patient underwent transsphenoidal surgery and histological findings showed a neoplasia with Ki-67 estimated at 75%. Medical imaging excluded both a primary occult tumor and central nervous system or systemic dissemination. Three weeks postoperatively, neurological condition worsened, with new onset of ataxia, bilateral ptosis, ophthalmoplegia and an increase in the size of the lesion, leading to surgical intervention by craniotomy, followed by only a few sessions of radiotherapy, because of severe disease progression. Patient died nearly 2 months after the initial manifestations. This case illustrates the aggressiveness of some pituitary lesions, the limited efficacy of current treatment modalities such as surgery or radiotherapy and the pitfalls of the current pituitary tumors classification. To our knowledge, this case corresponds to one of the most aggressive pituitary neoplasms reported so far, with a very high Ki-67 index (75%) and short survival (2 months). Ki-67 index could be of prognostic value in pituitary tumors. Pituitary tumors World Health Organization (WHO) classification could be revisited.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Gastroenterology & Hepatology

Chromogranin A and NSE in cystic pancreatic neuroendocrine tumors

Sandra Faias, Susana Prazeres, Mario Cunha, Luisa Pereira, Ruben Roque, Paula Chaves, Marilia Cravo, Isabe Claro, Margarida Silveira, Valeriano Leite, Dias Pereira

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2021)

Review Endocrinology & Metabolism

Serum Inflammation-based Scores in Endocrine Tumors

Pedro Marques, Friso de Vries, Olaf M. Dekkers, Marta Korbonits, Nienke R. Biermasz, Alberto M. Pereira

Summary: Serum inflammation-based scores have been shown to be valuable in predicting the risk, clinical aggressiveness, disease outcomes, and prognosis in patients with endocrine tumors. Parameters such as the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio have been extensively investigated in this patient population.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Review Endocrinology & Metabolism

Approach to the Patient With Pseudoacromegaly

Pedro Marques, Marta Korbonits

Summary: Pseudoacromegaly is a rare and heterogeneous group of conditions characterized by clinical features of acromegaly or gigantism, but without excess of GH or IGF-1. Establishing the underlying diagnosis can be challenging due to overlapping clinical features. Collaboration with clinical geneticists is crucial for the diagnosis of patients with genetic origins of pseudoacromegaly.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Endocrinology & Metabolism

The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours

Pedro Marques, Sayka Barry, Eivind Carlsen, David Collier, Amy Ronaldson, Joan Grieve, Neil Dorward, Nigel Mendoza, Ramesh Nair, Samiul Muquit, Ashley B. Grossman, Marta Korbonits

Summary: NCAM expression does not differ significantly between PitNETs and normal pituitary, and is not associated with tumor invasiveness or proliferation. However, cytokines like CXCL10, CX3CL1, and FGF-2 may play a role in modulating NCAM expression in PitNETs.

JOURNAL OF NEUROENDOCRINOLOGY (2021)

Article Endocrinology & Metabolism

The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications

Pedro Marques, Ana Luisa Silva, Dolores Lopez-Presa, Claudia Faria, Maria Joao Bugalho

Summary: The microenvironment of pituitary adenomas (PAs), consisting of non-tumoral cells and signaling molecules, plays a crucial role in tumor initiation, progression, and invasion. Recent studies have characterized immune and stromal cell populations, as well as various cytokines, chemokines, and growth factors in PAs. Key genes and immune-related molecules and pathways have also been investigated, with immune checkpoint regulators showing promise as targets for immunotherapy. Understanding the microenvironment of PAs provides insights into the complex biology of PAs and has implications for diagnosis, clinical management, and treatment of aggressive and refractory PAs.

PITUITARY (2022)

Review Cell Biology

Biochemical discrepancies in the evaluation of the somatotroph axis: Elevated GH or IGF-1 levels do not always diagnose acromegaly

Carolina Peixe, Miriam Sanchez-Garcia, Ashley B. Grossman, Marta Korbonits, Pedro Marques

Summary: When evaluating the somatotroph axis, it is important to consider the discrepancies in GH and IGF-1 levels in patients with acromegaly. These discrepancies may be due to early or partially treated disease, as well as other non-acromegaly causes such as pre-analytical and technical issues, physiological circumstances, and pathological conditions.

GROWTH HORMONE & IGF RESEARCH (2022)

Letter Endocrinology & Metabolism

Clinico-radiological features of acromegaly-related cutis verticis gyrata

Joao Roque, Pedro Marques

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2022)

Letter Medicine, General & Internal

Swift Reversal of Hypercortisolism-Related Dermatological Features Following Treatment in a Patient with Cushing's Disease

Maria Ines Alexandre, Pedro Miguel Garrido, Pedro Marques

ACTA MEDICA PORTUGUESA (2022)

Review Cell Biology

Acromegaly-related cutis verticis gyrata

Joao Roque, Pedro Marques

Summary: CVG is a rare benign skin lesion characterized by thickened and folded scalp, resembling the brain gyri and sulci. In acromegaly, CVG appears to be driven by the trophic effects of GH and IGF-1 on skin and soft tissues. Controlling the serum levels of GH and IGF-1 is essential for the management of acromegaly-related CVG.

GROWTH HORMONE & IGF RESEARCH (2022)

Letter Medicine, General & Internal

Calvaria thickening in acromegaly

Ines Cosme, Pedro Marques, Maria Joao Bugalho

MEDICINA CLINICA (2023)

Article Endocrinology & Metabolism

Clinical significance of papillary thyroid carcinoma with solid/trabecular growth

Sara Lomelino Pinheiro, Pedro Miranda Afonso, Ines Lemos Damasio, Joana Simoes-Pereira, Tiago Nunes da Silva, Valeriano Leite

Summary: The clinical relevance of solid/trabecular (ST) growth in papillary thyroid carcinoma (PTC) is unclear. This study found that ST growth in PTC was associated with larger tumor size and increased frequency of vascular invasion, but had no significant impact on patient prognosis in the absence of vascular invasion.

CLINICAL ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese cohort of 129 patients from a tertiary pituitary center

Carolina Peixe, Maria Ines Alexandre, Ana Raquel Gomes, Ema Nobre, Ana Luisa Silva, Tiago Oliveira, Dolores Lopez-Presa, Claudia C. Faria, Jose Miguens, Maria Joao Bugalho, Pedro Marques

Summary: A clinicopathological classification is useful in predicting the challenging disease course and treatment approach for patients with pituitary adenomas. Grade 2b tumors are more likely to require complex multimodal treatment and have higher rates of active disease at last follow-up.

PITUITARY (2023)

Review Endocrinology & Metabolism

Tumour microenvironment and pituitary tumour behaviour

P. Marques, M. Korbonits

Summary: The pituitary tumour microenvironment consists of various non-tumoural cells and signaling peptides, which can influence the behavior and development of pituitary tumours. Recent research has focused on immune and stromal cell subpopulations infiltrating pituitary tumours, as well as immune- and microenvironment-related pathways. Understanding the pituitary tumour microenvironment can improve the diagnosis and management of patients with aggressive or recurrent tumours.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Review Oncology

The Effects of Peptide Receptor Radionuclide Therapy on the Neoplastic and Normal Pituitary

Pedro Marques

Summary: Limited options are available for patients with aggressive or metastatic pituitary neuroendocrine tumours (PitNETs). Peptide receptor radionuclide therapy (PRRT), commonly used for gastroenteropancreatic neuroendocrine tumours, is being considered as a potential treatment for aggressive or metastatic PitNETs when other approaches fail. However, there is limited data on the use of PRRT in this context, mostly derived from case reports or small case series. This review examines the effectiveness and safety of PRRT in managing aggressive or metastatic PitNETs, as well as its effects on pituitary function in other cancer patients.

CANCERS (2023)

Article Endocrinology & Metabolism

Metastatic follicular thyroid cancer with a longstanding responsiveness to gemcitabine plus oxaliplatin

Daniela Dias, Ines Damasio, Pedro Marques, Helder Simoes, Ricardo Rodrigues, Branca Maria Cavaco, Valeriano Leite

Summary: This case report highlights the potential efficacy of GEMOX chemotherapy in patients with advanced follicular thyroid carcinoma resistant to multikinase inhibitors. The durable response to GEMOX significantly extended the overall survival of the patient.

EUROPEAN THYROID JOURNAL (2023)

暂无数据